Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2026)
Bionano Genomics (BNGO) posted Return on Capital Employed of 68.32% for Q1 2026, down 9.39% sequentially from 62.45% in Q4 2025, and up 9072.0% YoY from 0.74% in Q1 2025.
Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2026) Analysis & Trends
Bionano Genomics has reported Return on Capital Employed for 9 years, with the latest figure at 68.32% in Q1 2026.
- Quarterly Return on Capital Employed rose 9072.0% year-over-year to 68.32% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68.32% (up 9072.0% YoY) and the FY2025 annual result came in at 63.89%, up 3222.0% from the prior year.
- Return on Capital Employed fell to 68.32% in Q1 2026 per BNGO's latest filing, from 62.45% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 27.87% in Q1 2022 and troughed at 232.77% in Q4 2024.
- A 5-year average of 107.47% and a median of 68.32% in 2026 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed slumped 17227 bps in 2023, then jumped 17032 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 47.08% in 2022, then tumbled by 366 bps to 219.36% in 2023, then retreated by 6 bps to 232.77% in 2024, then surged by 73 bps to 62.45% in 2025, then retreated by 9 bps to 68.32% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 68.32%, 62.45%, and 67.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -69.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -69.74% |
| Mar 31, 2026 | -68.32% |
| Dec 31, 2025 | -62.45% |
| Sep 30, 2025 | -67.35% |
| Jun 30, 2025 | -135.96% |
| Mar 31, 2025 | -159.04% |
| Dec 31, 2024 | -232.77% |
| Sep 30, 2024 | -155.14% |
| Jun 30, 2024 | -174.93% |
| Mar 31, 2024 | -163.30% |
| Dec 31, 2023 | -219.36% |
| Sep 30, 2023 | -122.19% |
| Jun 30, 2023 | -59.11% |
| Mar 31, 2023 | -53.34% |
| Dec 31, 2022 | -47.08% |
| Sep 30, 2022 | -42.53% |
| Jun 30, 2022 | -36.32% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -22.25% |
| Sep 30, 2021 | -17.46% |